Patents by Inventor Albert Fliss

Albert Fliss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA
    Publication number: 20100227918
    Abstract: The present invention relates to a novel antimicrobial compound of lactoquinomycin that is highly effective against many antibiotic-resistant gram-positive bacteria; namely, methicillin-resistant and vancomycin-resistance Staphylococcus aureus, vancomycin-resistant Enterococcus faecilis and Mycobacteria. The present invention also relates to a fermentation process of culturing a Streptomyces strain to prepare the antimicrobial compound and its use in killing the antibiotic-resistant bacteria.
    Type: Application
    Filed: April 26, 2007
    Publication date: September 9, 2010
    Applicant: Taro Pharmaceuticals North America, Inc.
    Inventors: Albert Fliss, Arthur Bailey, Avraham Yacobi
  • Process of preparing prednisolone devoid of steroid-derived impurities using recombinant E. coli transformed with A delta¹-dehydrogenase gene
    Publication number: 20070015236
    Abstract: The present invention relates to a process of using recombinant E. coli having a ?1-dehydrogenase gene to prepare prednisolone. Specifically, the present invention relates to a fermentation process of using recombinant E. coli containing a ?1-dehydrogenase gene to prepare prednisolone that is devoid of steroid-derived impurities.
    Type: Application
    Filed: April 5, 2006
    Publication date: January 18, 2007
    Inventors: Albert Fliss, Horacio Bach